You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

camrelizumab、rivoceranib

Showing 1 - 1 of 1
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation

Recruiting
  • Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Jan 4, 2023